Severe adverse impact on sexual functioning and fertility of bone marrow transplantation, either allogeneic or autologous, compared with consolidation chemotherapy alone: analysis of the MRC AML 10 trial.

Severe adverse impact on sexual functioning and fertility of bone marrow transplantation, either allogeneic or autologous, compared with consolidation chemotherapy alone: analysis of the MRC AML 10 trial.

BACKGROUND: Data relating to the impact of bone marrow transplantation (BMT) on sexual functioning are equivocal; some studies have shown no major impact whereas others demonstrate a significant adverse effect on sexual health in patients treated with BMT. Further clarification is required to facili...

Detaylı Bibliyografya
Asıl Yazarlar:	Watson, M, Wheatley, K, Harrison, G, Zittoun, R, Gray, R, Goldstone, A, Burnett, A
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	1999

Benzer Materyaller

The value of allogeneic bone marrow transplant in patients with acute myeloid leukaemia at differing risk of relapse: results of the UK MRC AML 10 trial.
Yazar:: Burnett, A, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

The importance of diagnostic cytogenetics in older patients with AML: Analysis of 922 patients entered into the MRC AML 11 trial.
Yazar:: Grimwade, D, ve diğerleri
Baskı/Yayın Bilgisi: (1999)

Del(9q) AML: Clinical, cytological and cytogenetic characteristics and prognostic implications for patients entering the MRC AML trials.
Yazar:: Peniket, A, ve diğerleri
Baskı/Yayın Bilgisi: (1999)

Adverse impact of bone marrow transplantation on quality of life in acute myeloid leukaemia patients; analysis of the UK Medical Research Council AML 10 Trial.
Yazar:: Watson, M, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Impact of diagnostic cytogenetics on outcome in AML: Analysis of 1,613 patients entered into the UK MRC AML 10 trial.
Yazar:: Grimwade, D, ve diğerleri
Baskı/Yayın Bilgisi: (1996)

The presence of a FLT3 mutation in AML adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: Analysis of 854 patients from the MRC AML 10 and 12 trials.
Yazar:: Kottaridis, P, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

A simple, robust and highly predictive prognostic index for the determination of risk directed therapy in acute myeloid leukaemia (AML) derived from the United Kingdom medical research council (MRC) AML10 trial.
Yazar:: Wheatley, K, ve diğerleri
Baskı/Yayın Bilgisi: (1995)

Standard Consolidation/Maintenance Chemotherapy Is Consistently Superior to a Single Autologous Transplant for Adult Patients with Acute Lymphoblastic Leukemia: Results of the International ALL Trial (MRC UKALL XII/ECOG E2993).
Yazar:: Rowe, J, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties.
Yazar:: Grimwade, D, ve diğerleri
Baskı/Yayın Bilgisi: (1998)

In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993).
Yazar:: Goldstone, A, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

AML associated with previous cytotoxic therapy, MDS or myeloproliferative disorders: results from the MRC's 9th AML trial.
Yazar:: Hoyle, C, ve diğerleri
Baskı/Yayın Bilgisi: (1989)

Comparison of allogeneic transplant versus chemotherapy for relapsed childhood acute lymphoblastic leukaemia in the MRC UKALL R1 trial. MRC Childhood Leukaemia Working Party.
Yazar:: Harrison, G, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

Comparison of allogeneic transplant versus chemotherapy for relapsed childhood acute lymphoblastic leukaemia in the MRC UKALL R1 trial
Yazar:: Harrison, G, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

Feasibility and efficacy of maintenance chemotherapy following autologous bone marrow transplantation for first remission acute lymphoblastic leukaemia.
Yazar:: Tiley, C, ve diğerleri
Baskı/Yayın Bilgisi: (1993)

Survival after allogeneic bone marrow transplantation (BMT) in patients randomised into a trial of IFN-alpha versus chemotherapy: No significant adverse effect of prolonged IFN-alpha administration.
Yazar:: Shepherd, P, ve diğerleri
Baskı/Yayın Bilgisi: (1995)

Outcome for children with relapsed acute myeloid leukaemia following initial therapy in the Medical Research Council (MRC) AML 10 trial. MRC Childhood Leukaemia Working Party.
Yazar:: Webb, D, ve diğerleri
Baskı/Yayın Bilgisi: (1999)

How to avoid bias when comparing bone marrow transplantation with chemotherapy.
Yazar:: Gray, R, ve diğerleri
Baskı/Yayın Bilgisi: (1991)

Comparison of bone marrow transplant and chemotherapy for relapsed childhood acute lymphoblastic leukaemia: the MRC UKALL X experience
Yazar:: Wheeler, K, ve diğerleri
Baskı/Yayın Bilgisi: (1998)

Favorable results of allogeneic bone marrow transplantation (BMT) for adults with Philadelphia (Ph)-chromosome-negative acute lymphoblastic leukemia (ALL) in first complete remission (CR): Results from the International ALL trial (MRC UKALL XII/ECOG E2993).
Yazar:: Rowe, J, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial.
Yazar:: Grimwade, D, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Adverse outcome of human islet-allogeneic blood interaction.
Yazar:: Titus, T, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

T cell depletion with CAMPATH-1 in allogeneic bone marrow transplantation.
Yazar:: Hale, G, ve diğerleri
Baskı/Yayın Bilgisi: (1988)

Comparison of 1 + 5 DAT and 3 + 10 DAT followed by COAP or MAZE consolidation therapy in the treatment of acute myeloid leukemia: MRC ninth AML trial.
Yazar:: Rees, J, ve diğerleri
Baskı/Yayın Bilgisi: (1987)

The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials.
Yazar:: Kottaridis, P, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Delays in Post-Remission Chemotherapy for Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia are Associated with Inferior Outcomes in Patients who Undergo Allogeneic Transplant: An Analysis from ECOG 2993/MRC UK ALLXII.
Yazar:: Kumar, A, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Syntax of either in either… or… sentences
Yazar:: Wu, Danfeng
Baskı/Yayın Bilgisi: (2022)

No evidence that CD33 splicing SNP impacts the response to GO in younger adults with AML treated on UK MRC/NCRI trials
Yazar:: Gale, R, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Immune reconstitution after allogeneic bone marrow transplantation depleted of T cells.
Yazar:: Davison, G, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

Immune reconstitution following allogeneic bone marrow transplantation depleted of T-cells.
Yazar:: Davison, G, ve diğerleri
Baskı/Yayın Bilgisi: (1998)

Immune reconstitution post T-CELL depleted allogeneic bone marrow transplantation
Yazar:: Davison, G, ve diğerleri
Baskı/Yayın Bilgisi: (1998)

Autologous bone marrow clot as an alternative to autograft for bone defect healing
Yazar:: Lim, Z. X. H., ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Del (9q) AML: clinical and cytological characteristics and prognostic implications.
Yazar:: Peniket, A, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Excessive T-cell depletion adversely affects transplant-related mortality following allogeneic stem cell transplantation.
Yazar:: Chakraverty, R, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

Induction of tumour rejection by autologous and allogeneic tumour cells expressing B7.1 and IL-2.
Yazar:: Hirst, W, ve diğerleri
Baskı/Yayın Bilgisi: (1996)

Bone marrow transplantation induces either clonal deletion or infectious tolerance depending on the dose.
Yazar:: Bemelman, F, ve diğerleri
Baskı/Yayın Bilgisi: (1998)

Developing a dedicated dermatology service for allogeneic bone marrow transplant recipients
Yazar:: Danby, R, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

The role of molecular diagnosis and residual disease monitoring in APL: Results of the MRC ATRA trial.
Yazar:: Grimwade, D, ve diğerleri
Baskı/Yayın Bilgisi: (1998)

A randomized assessment of adding the kinase inhibitor lestaurtinib to first-line chemotherapy for FLT3-mutated AML
Yazar:: Knapper, S, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

The role of AML secretome and bone marrow microenvironment in establishment and maintenance of leukaemia initiating cells
Yazar:: Ren, X
Baskı/Yayın Bilgisi: (2023)

COMBINED USE OF CAMPATH-1G IN-VIVO AND IN THE BAG IN ALLOGENEIC BONE-MARROW TRANSPLANTATION
Yazar:: Fibbe, W, ve diğerleri
Baskı/Yayın Bilgisi: (1993)